Shenzhen Weiguang Biological Products Co (SZSE:002880) Ending Cash Position : ¥336 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co Ending Cash Position?

Shenzhen Weiguang Biological Products Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥336 Mil.

Shenzhen Weiguang Biological Products Co's quarterly Ending Cash Position increased from Sep. 2023 (¥192 Mil) to Dec. 2023 (¥251 Mil) and increased from Dec. 2023 (¥251 Mil) to Mar. 2024 (¥336 Mil).

Shenzhen Weiguang Biological Products Co's annual Ending Cash Position declined from Dec. 2021 (¥332 Mil) to Dec. 2022 (¥294 Mil) and declined from Dec. 2022 (¥294 Mil) to Dec. 2023 (¥251 Mil).

Shenzhen Weiguang Biological Products Co Ending Cash Position Historical Data

The historical data trend for Shenzhen Weiguang Biological Products Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Weiguang Biological Products Co Ending Cash Position Chart

Shenzhen Weiguang Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

304.48

471.38

332.01

293.85

251.45

Shenzhen Weiguang Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															311.08	355.92	192.24	251.45	336.34

Shenzhen Weiguang Biological Products Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Shenzhen Weiguang Biological Products Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	293.853	+	-42.408
	=	251

Shenzhen Weiguang Biological Products Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	251.477	+	84.867
	=	336

Shenzhen Weiguang Biological Products Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Shenzhen Weiguang Biological Products Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107

Website

http://www.szwg.com

Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines